Related Experiment Video
Updated: Jul 26, 2025

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring
Published on: May 17, 2024
The association between a single abnormal glucose and fetal c-peptide
Samantha de Los Reyes1, Annie Dude2, Jennifer Doll3
1Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, NorthShore University HealthSystem/University of Chicago, 2650 Ridge Ave., Walgreen Building, Evanston, IL, 60201, USA. delosreyes.samantha@gmail.com.
Insights
Fetuses exposed to one elevated glucose tolerance test (GTT) value showed higher fetal C-peptide levels, indicating a physiologic difference. This finding suggests potential implications for fetal development in pregnancies with mild glucose intolerance.
Area of Science:
- Perinatal medicine
- Endocrinology
- Obstetrics
Background:
- Gestational diabetes mellitus (GDM) screening involves glucose tolerance tests (GTT).
- The impact of mild glucose intolerance on fetal physiology is not fully understood.
- Fetal C-peptide levels reflect fetal insulin production.
Purpose of the Study:
- To determine if fetuses of mothers with one elevated GTT value exhibit different C-peptide levels compared to those with normal GTT results.
- To investigate the physiological differences in fetal insulin secretion based on maternal glucose tolerance.
Main Methods:
- Prospective cohort study comparing singleton, non-anomalous fetuses.
- Fetal C-peptide levels measured in cord blood.
- Data analyzed using univariable analysis after log transformation and outlier exclusion.
Main Results:
- Fetal C-peptide levels were significantly higher in the group with one elevated GTT value (4.6 ± 0.8 pmol/L) versus the normal GTT group (4.3 ± 0.7 pmol/L, P=0.046).
- No significant differences were observed in maternal characteristics or adverse perinatal outcomes between the groups.
Conclusions:
- Fetuses of mothers with one elevated GTT value demonstrate a measurable physiological difference in C-peptide levels.
- This suggests that even mild maternal glucose intolerance may influence fetal endocrine function.
Aim:
We aimed to evaluated if fetuses of subjects with one elevated value on the 3-h GTT had a measurable physiologic difference in fetal C-peptide levels as compared to those with no elevated values on the GTT.
Methods:
We performed a prospective cohort study to evaluate insulin levels in singleton non-anomalous fetuses of subjects with one elevated value on the GTT as compared to subjects with no elevated values on their GTT. Fetal insulin levels were measured by fetal C-peptide in cord blood. Distribution of data was assessed and outliers representing values > the 99th and < the 1st percentiles were excluded. Data were log transformed to achieve normal distribution and univariable analyses were performed to compare fetal C-peptide levels, baseline maternal characteristics and perinatal outcomes in subjects with one elevated value as compared those with no elevated values.
Results:
Our analysis included 99 subjects, with 49 subjects in the one elevated value group and 50 subjects in the no elevated values group. Fetal C-peptide levels (picomoles per liters, pmol/L), were significantly higher in the elevated value group as compared to the no elevated value group (mean ± SD; 4.6 ± 0.8 vs. 4.3 ± 0.7, P = 0.046, respectively). In univariable analysis, there was no significant difference in maternal characteristics or adverse composite perinatal outcomes.
Conclusion:
Fetuses of subjects who had one elevated value on their GTT had a measurable physiologic difference in C-peptide levels as compared to fetuses of subjects with no elevated values on the GTT.
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Cell Specific Gene Expression
Diabetes Mellitus: Type 2 and Gestational
Hypoglycemia and Glucagon
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...

